This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignee: Szegedi Tudomanyegyetem. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: The Innovative Contributions of István Mándity
Introduction
István Mándity is a notable inventor based in Szeged, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new morphine derivatives. His work focuses on enhancing the efficacy and safety of pain management treatments.
Latest Patents
Mándity holds a patent for "Deuterated morphine derivatives." This invention relates to new morphine derivatives that are deuterated at the 7,8-position of the morphine ring. The patent outlines a process for the preparation of these derivatives and pharmaceutical compositions that include them. The new deuterated morphine derivatives exhibit high and selective μ-opioid receptor binding activity. This leads to higher analgesic activity at lower dosages, thereby reducing adverse effects compared to traditional hydrogenated derivatives. These compounds are particularly useful in treating pain and can also serve as antitussive agents with a lower risk of drug abuse.
Career Highlights
Mándity is affiliated with Szegedi Tudományegyetem, where he conducts his research and development work. His innovative approach to pharmaceutical chemistry has positioned him as a key figure in the field.
Collaborations
Mándity has collaborated with notable colleagues, including Ferenc Fülöp and Balázs Olasz. Their combined expertise contributes to the advancement of research in pharmaceutical applications.
Conclusion
István Mándity's contributions to the development of deuterated morphine derivatives represent a significant advancement in pain management therapies. His work not only enhances the effectiveness of treatment but also aims to minimize the risks associated with traditional opioid medications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile